Cheratocono – Oftalmedica

Glaukos Avedro
Cross-linking

The only therapy of
keratoconus approved
by the FDA
(United States Food and Drug Administration)

The cross-linking procedure patented by
Glaukos Avedro is the first and only therapy approved by the
United States Food and Drug Administration
which strengthens the cornea and slows down the progression of keratoconus

Keratoconus is a condition in which the normal spherical shape of the cornea becomes thinner and progressively weakens causing a cone-shaped deformation.

This deformation can cause a severe deterioration of vision and in the most advanced cases the progressive thinning of the cornea can make a cornea transplant necessary.

Keratoconus is a rare disease, typically diagnosed in the early twenties, and can progress for ten to twenty years before slowing down or leveling off.

Keratoconus is always bilateral but the two eyes can be affected differently.

The main symptoms are:

Blurry vision
Distorted vision
Increased sensitivity to light

Keratoconus therapies correct distorted vision caused by corneal deformation and strengthen or repair its structure.

Currently the options are:

Glasses
Hard contact lenses
Corneal implants
Corneal cross-linking
Corneal transplant

Keratoconus in the absence of adequate treatment
can cause severe vision loss
and may require multiple corneal transplants,
seriously threatening the quality of life of patients

Corneal cross-linking is a minimally invasive procedure that combines the use of eye drops with Vitamin B2 and an ultraviolet system to stop the progression of keratoconus.

It creates new cross-links between the collagen fibers that make up the cornea
The fibrils shorten and become thicker
The cornea becomes stiffer and firmer

The ophthalmologist will apply some eye drops which will be left to rest for about 10 minutes.

The eye will then be exposed to ultraviolet rays for 10 minutes and the treatment is complete.

Avoid rubbing your eyes for five days after the procedure.
You may notice discomfort in the light and a foreign body sensation, using sunglasses will help you feel better.
You may wear protective contact lenses

Following treatment with Glaukos Avedro KXL it is very important that you follow your doctor's instructions and that you show up on time for checkups to avoid unpleasant complications.

Glaukos AvedroCross-linkingThe only therapy ofkeratoconus approvedby the FDA(United States Food and Drug Administration)

The cross-linking procedure patented byGlaukos Avedro is the first and only therapy approved by theUnited States Food and Drug Administrationwhich strengthens the cornea and slows down the progression of keratoconus

Keratoconus in the absence of adequate treatmentcan cause severe vision lossand may require multiple corneal transplants,seriously threatening the quality of life of patients

Glaukos Avedro cross-linking is available at

Aci Castello - Doctors Zagari

Bologna - Dr. Muraca Perrone

Bologna-Sant'Orsola - Prof. Luigi Fontana

Brescia - Eyecare eye centre

Cagliari - Dr. Paolo Tronci

Campobasso - Dr. Paolo Polisena

Castel San Pietro Terme - Dr. Rocco De Fazio

Catania - Dr. Francesco Famà

Catanzaro - Dr. Miguel Rechichi

Conegliano Veneto - Dr. Giovanni Prosdocimo

Correggio - Dr Marco Vecchi

Cosenza - Dr. Miguel Rechichi

Cuneo - Dr. Guido Caramello

Domodossola - Dr. Romolo Protti

Genoa - Health Ultralaser

Lugano - Dr. Lorenzo Artaria

Mascalucia - Dr. Salvatore Lo Grasso

Mestre - Dr. Dario Surace

Milan - Dr. Francesco Carones

Milan - Quattroelle eye studio

Modena - Dr. Paola Benedetti

Modena - Dr. Gianmaria Cavallini

Modena - Dr. Federico Nizzola

Morrovalle - Dr. Vincenzo Ramovecchi

Naples - Day Surgery Center

Naples - Dr. Alfredo Venosa

Naples - VanvitelliI University Hospital

Padua - Dr Paolucci Pierpaolo

Parma - Dr. Claudio Macaluso

Pavia - Dr. Roberto Ceccuzzi

Piacenza - Dr. Luigi Lodigiani

Pisa - Dr. Marco Fantozzi

Reggio Calabria - Dr. Demetrio Spinelli

Rome - Prof. Aldo Caporossi

Rome - Gemelli Hospital

Rome - Dr. Luca Gualdi

Rovigo - Dr. Luigi Caretti

San Benedetto del Tronto - Dr. Luca Cesari

San Severino Marche - Dr. Vincenzo Ramovecchi

Sassari - Dr. Paola Piccinini

Selargius - Dr. Miguel Rechichi

Siena - Prof. Cosimo Mazzotta

Siena - Prof. Aldo Caporossi

Glaukos Avedro
Cross-linking

The only therapy of
keratoconus approved
by the FDA
(United States Food and Drug Administration)

The cross-linking procedure patented by
Glaukos Avedro is the first and only therapy approved by the
United States Food and Drug Administration
which strengthens the cornea and slows down the progression of keratoconus

Keratoconus in the absence of adequate treatment
can cause severe vision loss
and may require multiple corneal transplants,
seriously threatening the quality of life of patients